{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:16Z","timestamp":1786996756469,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":624,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.seizure.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T08:58:12Z","timestamp":1309856292000},"page":"723-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient"],"prefix":"10.1016","volume":"20","author":[{"given":"Poh-Shiow","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Nien","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2011.06.001_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/1086508X.2008.11079655","article-title":"Diagnosis of nonconvulsive status epilepticus (NCSE) in adults with altered mental status: clinico-electroencephalographic considerations","volume":"48","author":"Bearden","year":"2008","journal-title":"Am J Electroneurodiagn Technol"},{"issue":"Suppl 8","key":"10.1016\/j.seizure.2011.06.001_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1528-1167.2007.01345.x","article-title":"EEG criteria for nonconvulsive status epilepticus","volume":"48","author":"Kaplan","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl 8","key":"10.1016\/j.seizure.2011.06.001_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2007.01347.x","article-title":"How urgent is the treatment of nonconvulsive status epilepticus?","volume":"48","author":"Thomas","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl 8","key":"10.1016\/j.seizure.2011.06.001_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1528-1167.2007.01364.x","article-title":"Status epilepticus treatment guidelines","volume":"48","author":"Kalviainen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.06.001_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2011.06.001_bib0030","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2011.06.001_bib0035","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2011.06.001_bib0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2011.06.001_bib0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1059-1311(03)00028-1","article-title":"Oral ketamine in paediatric non-convulsive status epilepticus","volume":"12","author":"Mewasingh","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2011.06.001_bib0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.yebeh.2007.12.002","article-title":"Nonconvulsive status epilepticus","volume":"12","author":"Maganti","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"Suppl 8","key":"10.1016\/j.seizure.2011.06.001_bib0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1528-1167.2007.01350.x","article-title":"Which anesthetic should be used in the treatment of refractory status epilepticus?","volume":"48","author":"Rossetti","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.06.001_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1167.2009.02297.x","article-title":"Nonconvulsive status epilepticus and coma","volume":"51","author":"Bauer","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.06.001_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","article-title":"Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity","volume":"4","author":"Ubogu","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2011.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2011.06.001_bib0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","article-title":"Ketamine successfully terminates malignant status epilepticus","volume":"82","author":"Pruss","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2011.06.001_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0b013e3181d1e3cd","article-title":"Terminating prolonged refractory status epilepticus using ketamine","volume":"33","author":"Hsieh","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2011.06.001_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0013-4694(64)90149-X","article-title":"The significance of periodic lateralized epileptiform discharges in eeg: an electrographic, clinical and pathological study","volume":"17","author":"Chatrian","year":"1964","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2011.06.001_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2011.06.001_bib0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"N-methyl-d-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.seizure.2011.06.001_bib0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4522(03)00027-7","article-title":"N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy","volume":"118","author":"Brandt","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.seizure.2011.06.001_bib0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2011.06.001_bib0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"issue":"Suppl 9","key":"10.1016\/j.seizure.2011.06.001_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2008.01928.x","article-title":"Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs","volume":"49","author":"Wasterlain","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2011.06.001_bib0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2011.06.001_bib0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpain.2009.09.005","article-title":"Use of oral ketamine in chronic pain management: a review","volume":"14","author":"Blonk","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.seizure.2011.06.001_bib0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/bja\/53.8.805","article-title":"Pharmacokinetics and analgesic effects of i.m. and oral ketamine","volume":"53","author":"Grant","year":"1981","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.seizure.2011.06.001_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur J Pharmacol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131111001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131111001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:40:24Z","timestamp":1761010824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131111001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1059131111001609"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2011.06.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2011.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}